AP -- Biotechnology company RXi Pharmaceuticals Corp. said Monday it is collaborating with Mirna Therapeutics on research to develop cancer treatments. Financial terms of the deal were not disclosed. RXi develops drugs that use “gene silencing” technology, which is designed to turn off the protein that causes a disease.
